Your browser doesn't support javascript.
loading
A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma.
Jo, Jung Hyun; Jung, Dawoon E; Lee, Hee Seung; Park, Soo Been; Chung, Moon Jae; Park, Jeong Youp; Bang, Seungmin; Park, Seung Woo; Cho, Sangsook; Song, Si Young.
Afiliación
  • Jo JH; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Jung DE; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee HS; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Park SB; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Chung MJ; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Park JY; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Bang S; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Park SW; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Cho S; CG Pharmaceuticals, Orinda, California, USA.
  • Song SY; CrystalGenomics, Seongnamsi, Gyeonggido, South Korea.
Int J Cancer ; 151(9): 1565-1577, 2022 11 01.
Article en En | MEDLINE | ID: mdl-35657348

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma Límite: Humans Idioma: En Revista: Int J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma Límite: Humans Idioma: En Revista: Int J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur